Episode Details
Back to Episodes
EP222: A Fishy Tail of Confusion
Description
Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.
Podcast Summary
Dr. Warrick Bishop, a practicing cardiologist and author, hosts this educational podcast dedicated to helping patients understand heart health. In this episode, Dr. Bishop explores the science behind fish oil supplementation, examining the evidence for its cardiovascular benefits and clarifying the roles of its two main components: EPA (eicosapentaeic acid) and DHA (docosahexaeonic acid). The discussion reveals surprising findings about which forms of fish oil are actually effective and introduces related treatment strategies for high-risk patients.
Key Takeaways:
-
Fish oil contains two main active components—EPA and DHA—that are commonly listed on supplement labels, but the evidence for their individual and combined benefits remains unclear.
-
Low-dose fish oil supplements (like standard fish oil tablets) show minimal to no outcome benefit for intermediate-risk individuals, as demonstrated by recent studies.
-
Purified EPA at pharmacological doses (approximately 4 grams daily) has demonstrated dramatic risk reduction in high-risk individuals with elevated triglycerides, as proven by the REDUCE-IT and JELIS trials.
-
Combinations of EPA and DHA have not shown clear outcome benefits in clinical trials, suggesting that mixing the two compounds may negate EPA's beneficial effects, though the mechanism is unknown.
-
Raised triglyceride levels may be a marker for underlying insulin resistance and inflammatory processes, making triglyceride management a key health priority.
-
Phenofibrate (lipidil), a fibrate agent, is highly effective for reducing microvascular complications in diabetic patients, particularly preventing diabetic eye disease and peripheral amputation.
-
Eating whole fish remains a healthy dietary choice, though the interaction between EPA and DHA in natural fish sources has not been studied.
-
High-risk patients with cardiovascular disease, elevated triglycerides, and pre-diabetic or diabetic status should discuss purified EPA supplementation with their healthcare provider.
-
For diabetic patients with raised triglycerides, phenofibrate is considered essential for preserving vision and peripheral circulation to prevent blindness and limb loss.